PANCRELIPASE - PANCRELIPASE
Navigation: NDC > Supplier starting with: K > KAISER FOUNDATION HOSPITALS| Field | Value |
|---|---|
| NDC Code: | 0179-0020 |
| Proprietary Name: | PANCRELIPASE |
| Suffix: | |
| Non-Proprietary Name: | PANCRELIPASE |
| Dosage Form: | CAPSULE, DELAYED RELEASE |
| Method: | ORAL |
| Original Marketing Date: | 01-02-2010 |
| Category Name: | UNAPPROVED DRUG OTHER |
| Application Number: | |
| Labeler: | KAISER FOUNDATION HOSPITALS |
| Substance Name: | PANCRELIPASE AMYLASE; PANCRELIPASE LIPASE; PANCRELIPASE PROTEASE |
| Active Numerator Strength: | 56000; 20000; 44000 |
| Active Ingredient Unit: | [USP'U]/1; [USP'U]/1; [USP'U]/1 |
| Pharm Classes: | |
| DEA Schedule: |